Ballicules.com
Not available in the U.S.

Celiprolol

Celiprolol ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Celiprolol ballicule

What it isA cardioselective beta-1 adrenergic antagonist with partial beta-2 agonist and mild vasodilatory activity.

Why this oneUsed outside the US for hypertension and shown to reduce arterial events in vascular Ehlers-Danlos syndrome.

What limits itA P-glycoprotein and OATP substrate whose absorption is reduced by food and by transporter-modulating drugs.

Celiprolol molecular structure (skeletal formula)
Molecular structure: Celiprolol

NO BOXED WARNINGS

Principal riskNo FDA boxed warning.

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Sedation liability1 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Open Celiprolol in the interactive console ↗